Background: Osteoarthritis is a major cause of pain and disability worldwide, therefore ways of treating this condition are paramount to a successful health system. The purpose of the study was to investigate the changes in spatial-temporal gait parameters and clinical measurements following treatment with a non-invasive foot-worn biomechanical device on patients with knee osteoarthritis within the UK.
Methods: A retrospective analysis was carried out on 455 patients with knee osteoarthritis. All patients were evaluated using a computerized gait test and two self-assessment questionnaires (WOMAC and SF-36) at baseline and after 3 and 6 months of treatment. The biomechanical device is a shoe-like device with convex pods under the sole that have the capability of changing foot centre of pressure and training neuromuscular control. The device was individually calibrated for each patient to minimise symptoms whilst walking and train neuromuscular control. Patients used the device for short periods during activities of daily living. Repeated measures statistical analyses were performed to compare differences over time.
Results: After 6 months of treatment significant improvements were seen in all gait parameters (p<0.01). Specifically, gait velocity, step length and single limb support of the more symptomatic knee improved by 13%, 7.8% and 3%, respectively. These were supported by significant improvements in pain, function and quality of life (48.6%, 45.7% and 22% respectively; p<0.001). A sub-group analysis revealed no baseline differences between those who were recommended joint replacement and those who were not. Both groups improved significantly over time (p<0.05 for all).
Conclusions: Our results suggest that the personalised biomechanical treatment can improve gait patterns, pain, function and quality of life. It may provide an additional solution to managing UK patients suffering from knee osteoarthritis but needs to be tested in a controlled setting first.

Figure 1

Figure 2

Figure 3
Loading...
Posted 04 Jun, 2020
On 29 May, 2020
On 28 May, 2020
On 26 May, 2020
On 26 May, 2020
On 26 May, 2020
Received 23 May, 2020
On 05 May, 2020
Received 03 May, 2020
On 01 May, 2020
Invitations sent on 28 Apr, 2020
On 21 Apr, 2020
On 20 Apr, 2020
On 20 Apr, 2020
On 02 Apr, 2020
Received 27 Mar, 2020
Received 26 Mar, 2020
Received 26 Mar, 2020
On 23 Mar, 2020
On 19 Mar, 2020
Received 19 Mar, 2020
On 17 Mar, 2020
On 12 Mar, 2020
Invitations sent on 06 Mar, 2020
On 05 Mar, 2020
On 03 Mar, 2020
On 02 Mar, 2020
On 24 Feb, 2020
Posted 04 Jun, 2020
On 29 May, 2020
On 28 May, 2020
On 26 May, 2020
On 26 May, 2020
On 26 May, 2020
Received 23 May, 2020
On 05 May, 2020
Received 03 May, 2020
On 01 May, 2020
Invitations sent on 28 Apr, 2020
On 21 Apr, 2020
On 20 Apr, 2020
On 20 Apr, 2020
On 02 Apr, 2020
Received 27 Mar, 2020
Received 26 Mar, 2020
Received 26 Mar, 2020
On 23 Mar, 2020
On 19 Mar, 2020
Received 19 Mar, 2020
On 17 Mar, 2020
On 12 Mar, 2020
Invitations sent on 06 Mar, 2020
On 05 Mar, 2020
On 03 Mar, 2020
On 02 Mar, 2020
On 24 Feb, 2020
Background: Osteoarthritis is a major cause of pain and disability worldwide, therefore ways of treating this condition are paramount to a successful health system. The purpose of the study was to investigate the changes in spatial-temporal gait parameters and clinical measurements following treatment with a non-invasive foot-worn biomechanical device on patients with knee osteoarthritis within the UK.
Methods: A retrospective analysis was carried out on 455 patients with knee osteoarthritis. All patients were evaluated using a computerized gait test and two self-assessment questionnaires (WOMAC and SF-36) at baseline and after 3 and 6 months of treatment. The biomechanical device is a shoe-like device with convex pods under the sole that have the capability of changing foot centre of pressure and training neuromuscular control. The device was individually calibrated for each patient to minimise symptoms whilst walking and train neuromuscular control. Patients used the device for short periods during activities of daily living. Repeated measures statistical analyses were performed to compare differences over time.
Results: After 6 months of treatment significant improvements were seen in all gait parameters (p<0.01). Specifically, gait velocity, step length and single limb support of the more symptomatic knee improved by 13%, 7.8% and 3%, respectively. These were supported by significant improvements in pain, function and quality of life (48.6%, 45.7% and 22% respectively; p<0.001). A sub-group analysis revealed no baseline differences between those who were recommended joint replacement and those who were not. Both groups improved significantly over time (p<0.05 for all).
Conclusions: Our results suggest that the personalised biomechanical treatment can improve gait patterns, pain, function and quality of life. It may provide an additional solution to managing UK patients suffering from knee osteoarthritis but needs to be tested in a controlled setting first.

Figure 1

Figure 2

Figure 3
Loading...